Specially Appointed
Prof. TANI

• Specially Appointed Professor
  • Joji TANI, M.D., Ph.D.
• Specially Appointed Associate Professor
  • Ai MATSUBARA, M.D., Ph.D.
• Collaborative Faculty
  • Hiroshi HOSHIKAWA, M.D., Ph.D.
    （Professor, Department of Otorhinolaryngology）

①    Regional Healthcare Optimization
     ・Addressing doctor distribution and specialty imbalances
     ・Developing tailored medical provision models for Kagawa Prefecture
②    Medical Education Enhancement
     ・Strengthening support for regional quota students/doctors
     ・ Improving training programs for general practitioners and high-demand specialties
③    Healthcare Network Development
     ・ Fostering inter-institutional and multi-professional collaboration
     ・Optimizing doctor placements in underserved areas

These research projects aim to improve the quality and accessibility of regional healthcare in Kagawa Prefecture, addressing key challenges such as doctor distribution, specialty imbalances, and the unique needs of different communities. The findings will contribute to building a more sustainable and effective healthcare system for the region.

• Extrahepatic Cancer Risk in Patients with Hepatitis C Virus Infection Treated with Direct-Acting Antivirals. Tani J(1st), et al. Microorganisms. 2024 Sep 22;12(9):1926.
• Alpha-fetoprotein and des-gamma-carboxy prothrombin can predict the objective response of patients with hepatocellular carcinoma receiving durvalumab plus tremelimumab therapy. Saeki I,  Tani J(5th), et al. PLoS One. 2024 Sep 25;19(9)
• Predictive factors and survival outcome of conversion therapy for unresectable hepatocellular carcinoma patients receiving atezolizumab and bevacizumab: Comparative analysis of conversion, partial response and complete response patients. Hatanaka T, Tani J(6th), et al. Aliment Pharmacol Ther. 2024 Sep 4.